logo-loader
viewInnovaDerma PLC

Director/PDMR Shareholding

/**/ p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";} .aa{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.aa{}p.n,li.n,div.n{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}span.bm{color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}span.bj{font-size:10.0pt; font-family:"Arial","sans-serif";color:black}p.bn{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align: center}span.bo{font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}p.bp{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align: center}p.bq{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.br{font-size: 10.0pt;font-family:"Arial","sans-serif"} span.bg{color:black}span.bs{font-size: 10.0pt;font-family:"Arial","sans-serif";color:black}p.bt{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt; margin-left:0cm;text-align:justify;line-height:12.65pt}span.bu{font-size:10.0pt;font-family:"Arial","sans-serif";color:black}p.bv{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-weight: bold; line-height: normal; margin-bottom: 0cm}span.ba{font-size:10.0pt; font-family:"Arial","sans-serif"}table.bw{margin-left:-5.4pt;border-collapse:collapse;border:none}td.aw{width:214.6pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.bx{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-autospace: none}p.by{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal;text-autospace:none} td.av{width:214.6pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.at{width:214.6pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}span.au{font-size:10.0pt;font-family:"Arial","sans-serif"}td.as{width:214.6pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}span.ar{font-size:10.0pt;font-family:"Arial","sans-serif"; color:#0563C1}p.ao{font-weight: bold; line-height: 120%; margin-bottom: 3.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify}span.ap{font-size:11.0pt; line-height:120%;font-family:"Calibri","sans-serif";color:black}p.an{font-div: italic; font-weight: bold; line-height: 120%; margin-bottom: 3.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify}table.bz{width:450.25pt;margin-left:-10.8pt;border-collapse:collapse}td.ak{width:45.85pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt} p.ca{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:11.5pt;font-family:"Arial","sans-serif";font-weight: bold; text-align: justify}span.am{font-size:11.0pt;font-family:"Calibri","sans-serif"}td.aj{width:382.8pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.ai{width:45.85pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}p.cb{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:11.5pt;font-family:"Arial","sans-serif";text-align:justify}td.ah{width:141.8pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ag{width:230.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.af{width:382.8pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ae{width:141.8pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ad{width:230.2pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt} span.cc{font-size:10.0pt}p.f,li.f,div.f{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";} /**/
RNS Number : 8574S
InnovaDerma PLC
08 November 2019
 

  LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

 Director/PDMR shareholding

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces that it was notified today, Joseph Bayer, Executive Chairman has purchased 21,666 Ordinary Shares of €0.10 each in the Company at a price of 65.25 pence per Ordinary Share which will be held via his Australian Superannuation Fund which Mr Bayer controls.  He now holds 114,999 via his Australian Superannuation Fund. 

Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 143,179 Ordinary Shares representing approximately 0.99% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

 

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

[email protected]

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joseph Bayer

2.               

Reason for the Notification

 

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial notification

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP         GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume -21,666 Ordinary Shares

Price -65.25 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

8 November 2019

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUWUVRKRAARAA

Quick facts: InnovaDerma PLC

Price: 60.5

Market: LSE
Market Cap: £8.77 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: InnovaDerma PLC launches limited edition chocolate range of...

InnovaDerma PLC's (LON:IDP) Kieran Callan speaks to Proactive London's Andrew Scott following the big launch in London of their ‘Choc’ range of Skinny Tan products. The range of five new products will be sold exclusively at Superdrug from early December.

3 weeks, 2 days ago